DNA sequencing giant Illumina just bought rival Pac Bio for $1.2 billion — here's why
November 01, 2018 at 17:13 PM EDT
Illumina made a move that will help it retain its dominance in the burgeoning DNA-sequencing field, experts say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|